Viveon Health Acquisition Corp. (VHAQ)
| Market Cap | 66.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 1.27M |
| Shares Out | 6.65M |
| EPS (ttm) | 0.15 |
| PE Ratio | 64.77 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,453 |
| Open | 10.00 |
| Previous Close | n/a |
| Day's Range | 10.00 - 10.00 |
| 52-Week Range | 0.00 - 12.48 |
| Beta | -0.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 31, 2025 |
About Viveon Health Acquisition
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC. [Read more]
Financial Performance
Financial StatementsNews
Meteora Capital, LLC Acquires New Holdings in Viveon Health Acquisition Corp
Meteora Capital, LLC Acquires New Holdings in Viveon Health Acquisition Corp
VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS
New York, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE American: VHAQ, VHAQR, VHAQU) a special purpose acquisition company (the “Company”) re-affirms its commitment to the pr...
VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION
Viveon combination with Clearday continues to move forward New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) a special purpose acqui...
Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE
Atlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: VHAQ, VHAQW, VHAQR, VHAQU the “Company”) announces that, as previously disclosed in the Current Report on Form 8-K...
VIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION
ATLANTA, GEORGIA, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (“Viveon” or the “Company”) announced t...
VIVEON HEALTH ACQUISITION CORP. RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING
New York, April 25, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (the “Company”) announced today, that on April ...
Viveon Health Acquisition Corp. Announces Termination of Merger Agreement with Suneva Medical, Inc.
Norcross, GA– , Feb. 03, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (the “Company” or “Viveon”), a special purpose acquisition company, announc...
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.
NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company (the “Company”), today announced that it h...
VIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022.
NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company (the “Company”), today announced that it w...
Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP Treatments
SAN DIEGO , Sept. 13, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative products to change the standard of care in pati...
Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Suneva Medical
SAN DIEGO & NORCROSS, Ga.--(BUSINESS WIRE)--Viveon Health Acquisition Corp. (NYSE: VHAQ) (“Viveon Health” or “VHAQ”), a special purpose acquisition company, and Suneva Medical, Inc. (“Suneva” or the “...
Suneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and Canada
Canadian Regulators have approved Dermapose® All-In-One fat sizing syringe U.S. FDA 510(k) clearance for a larger volume Amplifine PRP Gel Tube SAN DIEGO , May 3, 2022 /PRNewswire/ -- Suneva Medical,...
Viveon Health Acquisition Corp. Received Audit Opinion with Going Concern Explanation
NEW YORK--(BUSINESS WIRE)--Viveon Health Acquisition Corp. ("Viveon" or the "Company") (NYSE American: VHAQ) today announced that, as previously disclosed in its Annual Report on Form 10-K for the yea...
Viveon Health Acquisition Corp. Announces Board and Stockholder Approval to Extend Period to Consummate Business Combination
NORCROSS, Ga. , March 21, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE American: VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, announced the approval of its b...
Viveon Health Acquisition Corp. Announces Clarified Contribution Terms in Connection with the Extension Related to Merger Agreement with Suneva Medical
NORCROSS, Ga. , Feb. 11, 2022 /PRNewswire/ -- Viveon Health Acquisition Corp. (NYSE American: VHAQ) ("Viveon Health" or "VHAQ"), a special purpose acquisition company, today announced that it is clari...
Suneva Surpasses 1 Million Syringes of Bellafill® Distributed Since the Biostimulator's Inception
SAN DIEGO, Feb. 8, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthet...
FDA Accepts Label Update for Plasma IQ™, the First FDA-Cleared Handheld Plasma Energy Device
SAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standard of care in aesthe...
Regenerative Aesthetics Firm Suneva Medical Gets SPAC Support To Go Public
Suneva Medical Inc, medical aesthetics player, will soon form a reverse merger with Viveon Health Acquisition Corp (NYSE: VHAQ), a special purpose acquisition company. Viveon Health went public throug...
Suneva Medical Inc. and Viveon Health Acquisition Corp. Announce Merger Agreement to Create a Leading Regenerative Aesthetics Company
SAN DIEGO and NORCROSS, Ga., Jan. 12, 2022 /PRNewswire/ -- Suneva Medical, Inc. ("Suneva" or the "Company"), an innovative medical technology company using regenerative medicine to change the standar...